1. Opportunity Analysis and Industry Forecast, 2016-2023 Nuclear Medicine/Radiopharmaceuticals Market Global Opportunity Analysis and Industry Forecast, 2014-2022

2. Nuclear Medicine/Radiopharmaceuticals Market is expected to garner $8,207.5 million by 2022. The global radiopharmaceuticals market is poised to grow at a significant pace, owing to growing demand for non-invasive techniques, availability of effective cancer treatment, and ability to observe the functioning of the organ from outside the body. Furthermore, increasing incidence of cancer & cardiovascular aliments, growing demand for alpha radio immunotherapy-based targeted cancer treatment, mounting call for nuclear imaging techniques, and advancements in radiotracers are expected to open new avenues in the radiopharmaceuticals market. Factors that are expected to drive the use of radiopharmaceuticals include changing lifestyle, elevated levels of stress, and ability to identify various diseases sooner than other diagnostic tests. However, factors such as supply volatility & logistical challenges, stringent regulatory vigil, and competition from conventional diagnostic procedures are anticipated to impede the market growth. Introduction of Nuclear Medicine/Radiopharmaceuticals Market

3. Scope ofthe Report Key Benefits Key Audiences Introduction of Nuclear Medicine/Radiopharmaceuticals Market

4. Key Benefits Therapeutics segment is projected to be the fastest growing segment in the radiopharmaceuticals market, registering a CAGR of 16.9% from 2016 to 2022. SPECT modality segment is expected to dominate the radiopharmaceuticals market in 2015 and expected to retain its position throughout the study period. Thyroid application segment is expected to exhibit double-digit CAGR of 11%. Oncology application segment is expected to continue to lead the radiopharmaceuticals market, accounting for close to 60% share by 2022. Asia-Pacific is projected to be the fastest growing radiopharmaceuticals market, registering a CAGR of 8.4%.

5. Table of Content (TOC) Chapter: 1 Introduction Chapter: 2 Executive Summary Chapter: 3 Market Overview Chapter: 4 World Radiopharmaceuticals Market, By Type, 2014-2022 Chapter: 5 World Radiopharmaceuticals Market, By Modality, 2014-2022 Chapter: 6 World Radiopharmaceuticals Market, By Application, 2014-2022 Chapter: 7 World Radiopharmaceuticals Market, By End-user, 2014-2022 Chapter: 8 World Radiopharmaceuticals Market, By Geography, 2014-2022 Chapter: 9 Company Profiles

6. Segments Nuclear Medicine/Radiopharmaceuticals Market Segments Type Modality Application ProceduresEnd-user

7. Segments Nuclear Medicine/Radiopharmaceuticals Market Type Diagnostic Therapeutic

8. Segments Nuclear Medicine/Radiopharmaceuticals Market Modality SPECTPETAlpha-emittersBeta-emittersBrachytherapy

9. Segments Nuclear Medicine/Radiopharmaceuticals Market Application OncologyCardiologyNeurologyThyroid

10. Company Profiles Nuclear Medicine/Radiopharmaceuticals Market 1.Mallinckrodt plc. 2.General Electric Co. 3.Medtronic, plc. (Covidien, acquired by Medtronic ) 4.Bayer AG 5.Cardinal Health, Inc. 6.Lantheus Medical Imaging, Inc.

11. Follow Us On Thank You! For More Details Do Enquiry https://www.alliedmarketresearch.com/nuclear-medicine-radiopharmaceuticals-market Thank You Nuclear Medicine/Radiopharmaceuticals Market